- Home
- SDHC vs POM Comparison
SDHC vs POM Comparison
Compare SDHC & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SDHC
- POM
- Stock Information
- Founded
- SDHC 2008
- POM 2015
- Country
- SDHC United States
- POM China
- Employees
- SDHC N/A
- POM N/A
- Industry
- SDHC
- POM Other Specialty Stores
- Sector
- SDHC
- POM Consumer Discretionary
- Exchange
- SDHC Nasdaq
- POM Nasdaq
- Market Cap
- SDHC 794.4M
- POM 640.8M
- IPO Year
- SDHC 2024
- POM 2025
- Fundamental
- Price
- SDHC $17.29
- POM $5.25
- Analyst Decision
- SDHC Hold
- POM
- Analyst Count
- SDHC 4
- POM 0
- Target Price
- SDHC $16.63
- POM N/A
- AVG Volume (30 Days)
- SDHC 99.2K
- POM 3.2M
- Earning Date
- SDHC 11-05-2025
- POM 01-01-0001
- Dividend Yield
- SDHC N/A
- POM N/A
- EPS Growth
- SDHC N/A
- POM N/A
- EPS
- SDHC N/A
- POM N/A
- Revenue
- SDHC $998,173,000.00
- POM $46,931,528.00
- Revenue This Year
- SDHC $1.27
- POM N/A
- Revenue Next Year
- SDHC $8.41
- POM N/A
- P/E Ratio
- SDHC $78.49
- POM N/A
- Revenue Growth
- SDHC 10.26
- POM 12.37
- 52 Week Low
- SDHC $15.00
- POM $3.47
- 52 Week High
- SDHC $37.90
- POM $6.43
- Technical
- Relative Strength Index (RSI)
- SDHC 49.44
- POM N/A
- Support Level
- SDHC $16.65
- POM N/A
- Resistance Level
- SDHC $18.58
- POM N/A
- Average True Range (ATR)
- SDHC 0.82
- POM 0.00
- MACD
- SDHC 0.06
- POM 0.00
- Stochastic Oscillator
- SDHC 43.95
- POM 0.00
About SDHC Smith Douglas Homes Corp.
Smith Douglas Homes Corp is a company engaged in the design, construction, and sale of single-family homes in some of the highest growth and desirable markets in the Southeastern United States. It is organized into eight geographical divisions which comprise two reportable segments. Its Southeast segment consists of Atlanta, Central Georgia, Charlotte, Greenville, and Raleigh divisions. Its Central segment consists of Alabama, Houston, and Nashville divisions.
About POM POMDOCTOR LIMITED American Depositary Shares
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.